Yida Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yida Wang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Guang Yang
Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China
2 shared publications Chen Chen
Department of MRI The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
1 shared publicationChenglong Wang
Shanghai Key Laboratory of Magnetic Resonance East China Normal University Shanghai China
1 shared publicationChunyan Zhang
Department of MRI The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
1 shared publication- Ewart Mark Haacke
Department of Neurology, Wayne State University, Detroit, MI, USA; Department of Radiology, Wayne State University, Detroit, MI, USA
1 shared publication Fangtao Liu
Department of Radiology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication
Latest Publications
- 12 March 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (6) , 2730-2742
Fully Automated Identification of Lymph Node Metastases and Lymphovascular Invasion in Endometrial Cancer From Multi‐Parametric MRI by Deep Learning
Background: Early and accurate identification of lymphatic node metastasis (LNM) and lymphatic vascular space invasion (LVSI) for endometrial cancer (EC) patients is important for treatment design, but difficult on multi‐parametric MRI (mpMRI) images.Purpose: To develop a deep learning (DL) model to simultaneously identify of LNM and LVSI of EC from mpMRI images.Study Type: Retrospective.Population: Six hundred twenty‐one patients with histologically proven EC from two institutions, including 111 LNM‐positive and 168 LVSI‐positive, divided into training, internal, and external test cohorts of 398, 169, and 54 patients, respectively.Field Strength/Sequence: T2‐weighted imaging (T2WI), contrast‐enhanced T1WI (CE‐T1WI), and diffusion‐weighted imaging (DWI) were scanned with turbo spin‐echo, gradient‐echo, and two‐dimensional echo‐planar sequences, using either a 1.5 T or 3 T system.Assessment: EC lesions were manually delineated on T2WI by two radiologists and used to train an nnU‐Net model for automatic segmentation. A multi‐task DL model was developed to simultaneously identify LNM and LVSI positive status using the segmented EC lesion regions and T2WI, CE‐T1WI, and DWI images as inputs. The performance of the model for LNM‐positive diagnosis was compared with those of three radiologists in the external test cohort.Statistical Tests: Dice similarity coefficient (DSC) was used to evaluate segmentation results. Receiver Operating Characteristic (ROC) analysis was used to assess the performance of LNM and LVSI status identification. P value <0.05 was considered significant.Results: EC lesion segmentation model achieved mean DSC values of 0.700 ± 0.25 and 0.693 ± 0.21 in the internal and external test cohorts, respectively. For LNM positive/LVSI positive identification, the proposed model achieved AUC values of 0.895/0.848, 0.806/0.795, and 0.804/0.728 in the training, internal, and external test cohorts, respectively, and better than those of three radiologists (AUC = 0.770/0.648/0.674).Data Conclusion: The proposed model has potential to help clinicians to identify LNM and LVSI status of EC patients and improve treatment planning.Evidence Level: 3Technical Efficacy: Stage 2
- 12 March 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (6) , 2730-2742
Fully Automated Identification of Lymph Node Metastases and Lymphovascular Invasion in Endometrial Cancer From Multi‐Parametric MRI by Deep Learning
Background: Early and accurate identification of lymphatic node metastasis (LNM) and lymphatic vascular space invasion (LVSI) for endometrial cancer (EC) patients is important for treatment design, but difficult on multi‐parametric MRI (mpMRI) images.Purpose: To develop a deep learning (DL) model to simultaneously identify of LNM and LVSI of EC from mpMRI images.Study Type: Retrospective.Population: Six hundred twenty‐one patients with histologically proven EC from two institutions, including 111 LNM‐positive and 168 LVSI‐positive, divided into training, internal, and external test cohorts of 398, 169, and 54 patients, respectively.Field Strength/Sequence: T2‐weighted imaging (T2WI), contrast‐enhanced T1WI (CE‐T1WI), and diffusion‐weighted imaging (DWI) were scanned with turbo spin‐echo, gradient‐echo, and two‐dimensional echo‐planar sequences, using either a 1.5 T or 3 T system.Assessment: EC lesions were manually delineated on T2WI by two radiologists and used to train an nnU‐Net model for automatic segmentation. A multi‐task DL model was developed to simultaneously identify LNM and LVSI positive status using the segmented EC lesion regions and T2WI, CE‐T1WI, and DWI images as inputs. The performance of the model for LNM‐positive diagnosis was compared with those of three radiologists in the external test cohort.Statistical Tests: Dice similarity coefficient (DSC) was used to evaluate segmentation results. Receiver Operating Characteristic (ROC) analysis was used to assess the performance of LNM and LVSI status identification. P value <0.05 was considered significant.Results: EC lesion segmentation model achieved mean DSC values of 0.700 ± 0.25 and 0.693 ± 0.21 in the internal and external test cohorts, respectively. For LNM positive/LVSI positive identification, the proposed model achieved AUC values of 0.895/0.848, 0.806/0.795, and 0.804/0.728 in the training, internal, and external test cohorts, respectively, and better than those of three radiologists (AUC = 0.770/0.648/0.674).Data Conclusion: The proposed model has potential to help clinicians to identify LNM and LVSI status of EC patients and improve treatment planning.Evidence Level: 3Technical Efficacy: Stage 2
- Open Access
- 19 June 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (12) , 4426-4438
An automatic interpretable deep learning pipeline for accurate Parkinson's disease diagnosis using quantitative susceptibility mapping and T1‐weighted images
Parkinson's disease (PD) diagnosis based on magnetic resonance imaging (MRI) is still challenging clinically. Quantitative susceptibility maps (QSM) can potentially provide underlying pathophysiological information by detecting the iron distribution in deep gray matter (DGM) nuclei. We hypothesized that deep learning (DL) could be used to automatically segment all DGM nuclei and use relevant features for a better differentiation between PD and healthy controls (HC). In this study, we proposed a DL‐based pipeline for automatic PD diagnosis based on QSM and T1‐weighted (T1W) images. This consists of (1) a convolutional neural network model integrated with multiple attention mechanisms which simultaneously segments caudate nucleus, globus pallidus, putamen, red nucleus, and substantia nigra from QSM and T1W images, and (2) an SE‐ResNeXt50 model with an anatomical attention mechanism, which uses QSM data and the segmented nuclei to distinguish PD from HC. The mean dice values for segmentation of the five DGM nuclei are all >0.83 in the internal testing cohort, suggesting that the model could segment brain nuclei accurately. The proposed PD diagnosis model achieved area under the the receiver operating characteristic curve (AUCs) of 0.901 and 0.845 on independent internal and external testing cohorts, respectively. Gradient‐weighted class activation mapping (Grad‐CAM) heatmaps were used to identify contributing nuclei for PD diagnosis on patient level. In conclusion, the proposed approach can potentially be used as an automatic, explainable pipeline for PD diagnosis in a clinical setting.
- 19 June 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (12) , 4426-4438
Open AccessAn automatic interpretable deep learning pipeline for accurate Parkinson's disease diagnosis using quantitative susceptibility mapping and T1‐weighted images
Parkinson's disease (PD) diagnosis based on magnetic resonance imaging (MRI) is still challenging clinically. Quantitative susceptibility maps (QSM) can potentially provide underlying pathophysiological information by detecting the iron distribution in deep gray matter (DGM) nuclei. We hypothesized that deep learning (DL) could be used to automatically segment all DGM nuclei and use relevant features for a better differentiation between PD and healthy controls (HC). In this study, we proposed a DL‐based pipeline for automatic PD diagnosis based on QSM and T1‐weighted (T1W) images. This consists of (1) a convolutional neural network model integrated with multiple attention mechanisms which simultaneously segments caudate nucleus, globus pallidus, putamen, red nucleus, and substantia nigra from QSM and T1W images, and (2) an SE‐ResNeXt50 model with an anatomical attention mechanism, which uses QSM data and the segmented nuclei to distinguish PD from HC. The mean dice values for segmentation of the five DGM nuclei are all >0.83 in the internal testing cohort, suggesting that the model could segment brain nuclei accurately. The proposed PD diagnosis model achieved area under the the receiver operating characteristic curve (AUCs) of 0.901 and 0.845 on independent internal and external testing cohorts, respectively. Gradient‐weighted class activation mapping (Grad‐CAM) heatmaps were used to identify contributing nuclei for PD diagnosis on patient level. In conclusion, the proposed approach can potentially be used as an automatic, explainable pipeline for PD diagnosis in a clinical setting.
- Open Access
- 12 August 2021
- Published by Wiley in Genes, Brain and Behavior
- Vol. 20 (7) , e12763
Ccdc134 deficiency impairs cerebellar development and motor coordination
Coiled‐coil domain containing 134 (CCDC134) has been shown to serve as an immune cytokine to exert antitumor effects and to act as a novel regulator of hADA2a to affect PCAF acetyltransferase activity. While Ccdc134 loss causes abnormal brain development in mice, the significance of CCDC134 in neuronal development in vivo is controversial. Here, we report that CCDC134 is highly expressed in Purkinje cells (PCs) at all developmental stages and regulates mammalian cerebellar development in a cell type‐specific manner. Selective deletion of Ccdc134 in mouse neural stem cells (NSCs) caused defects in cerebellar morphogenesis, including a decrease in the number of PCs and impairment of PC dendritic growth, as well as abnormal granule cell development. Moreover, loss of Ccdc134 caused progressive motor dysfunction with deficits in motor coordination and motor learning. Finally, Ccdc134 deficiency inhibited Wnt signaling but increased Ataxin1 levels. Our findings provide evidence that CCDC134 plays an important role in cerebellar development, possibly through regulating Wnt signaling and Ataxin1 expression levels, and in controlling cerebellar function for motor coordination and motor learning, ultimately making it a potential contributor to cerebellar pathogenesis.
- 12 August 2021
- Published by Wiley in Genes, Brain and Behavior
- Vol. 20 (7) , e12763
Open AccessCcdc134 deficiency impairs cerebellar development and motor coordination
Coiled‐coil domain containing 134 (CCDC134) has been shown to serve as an immune cytokine to exert antitumor effects and to act as a novel regulator of hADA2a to affect PCAF acetyltransferase activity. While Ccdc134 loss causes abnormal brain development in mice, the significance of CCDC134 in neuronal development in vivo is controversial. Here, we report that CCDC134 is highly expressed in Purkinje cells (PCs) at all developmental stages and regulates mammalian cerebellar development in a cell type‐specific manner. Selective deletion of Ccdc134 in mouse neural stem cells (NSCs) caused defects in cerebellar morphogenesis, including a decrease in the number of PCs and impairment of PC dendritic growth, as well as abnormal granule cell development. Moreover, loss of Ccdc134 caused progressive motor dysfunction with deficits in motor coordination and motor learning. Finally, Ccdc134 deficiency inhibited Wnt signaling but increased Ataxin1 levels. Our findings provide evidence that CCDC134 plays an important role in cerebellar development, possibly through regulating Wnt signaling and Ataxin1 expression levels, and in controlling cerebellar function for motor coordination and motor learning, ultimately making it a potential contributor to cerebellar pathogenesis.